drugset / Trial / NCT00157898

A Study to Evaluate Ertapenem Versus It's Comparator in the Treatment of Complicated Intra-abdominal Infections in Adults (0826-050)(COMPLETED)

NCT00157898

Phase 4 Completed 134 enrolled Merck Sharp & Dohme LLC
RandomizedParallel-groupOpen-labelTreatment

Summary

This was a prospective, randomized, controlled, open, and multi-center trial conducted to compare the clinical efficacy and safety of ertapenem with it's comparator before or following adequate surgical management of complicated intra-abdominal infection.

Timeline

Start
2004-01
Primary completion
2004-08
Completion
2004-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Ceftriaxone Other / unclassified
Subject Ertapenem Small molecule
Subject Metronidazole Small molecule

Indications

No indication recorded.